Cargando…
Crystal structure of memantine–carboxyborane
The synthesis and crystal structure of the title compound, C(13)H(24)BNO(2) [systematic name: 3,5-dimethyladamantanylamine–boranecarboxylic acid or N-(carboxyboranylidene)-3,5-dimethyladamantan-1-amine], derived from the anti-Alzheimer’s disease drug memantine is reported. The C—N—B—CO(2)...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505612/ https://www.ncbi.nlm.nih.gov/pubmed/31110782 http://dx.doi.org/10.1107/S2056989019004092 |
Sumario: | The synthesis and crystal structure of the title compound, C(13)H(24)BNO(2) [systematic name: 3,5-dimethyladamantanylamine–boranecarboxylic acid or N-(carboxyboranylidene)-3,5-dimethyladamantan-1-amine], derived from the anti-Alzheimer’s disease drug memantine is reported. The C—N—B—CO(2) unit is almost planar (r.m.s. deviation = 0.095 Å). The extended structure shows typical carboxylic acid inversion dimers linked by pairwise O—H⋯O hydrogen bonds [O⋯O = 2.662 (3) Å]. The amino group forms a weak N—H⋯O hydrogen bond [N⋯O = 3.011 (3) Å], linking the dimers into [001] chains in the crystal. Highly disordered solvent molecules were treated using the SQUEEZE routine of PLATON [Spek (2015 ▸). Acta Cryst. C71, 9–18], which treats the electron density as a diffuse contribution without assignment of specific atom locations. A scattering contribution of 255 electrons was removed. The crystal studied was refined as a two-component twin. |
---|